Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
4.851
-0.139 (-2.79%)
Jun 3, 2026, 1:06 PM EDT - Market open
Silexion Therapeutics Employees
As of December 31, 2025, Silexion Therapeutics had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
14
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$922,143
Market Cap
2.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | 0 | - | 13 | 1 |
| Dec 31, 2024 | 14 | - | - | 11 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Calidi Biotherapeutics | 29 |
| Biodexa Pharmaceuticals | 11 |
| Ensysce Biosciences | 10 |
| GRI Bio | 4 |
| Oragenics | 3 |
SLXN News
- 5 days ago - Silexion Therapeutics Corp trading halted, news pending - TheFly
- 8 days ago - Silexion Therapeutics announces 1-for-10 reverse share split - TheFly
- 8 days ago - Silexion Therapeutics Announces 1-for-10 Reverse Share Split - GlobeNewsWire
- 12 days ago - 3 Penny Stocks to Watch Now, 5/21/26 - TipRanks
- 16 days ago - Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 19 days ago - Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds - GlobeNewsWire
- 20 days ago - Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer - GlobeNewsWire
- 21 days ago - Silexion Therapeutics initiates GMP clinical batch manufacturing of SIL204 - TheFly